Idera Pharmaceuticals Inc Stock Nasdaq
Equities
US45168K3068
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | 4.86M 6.65M | Capitalization | 3.12M 4.27M |
---|---|---|---|---|---|
Net income 2021 | 98M 134M | Net income 2022 | -23M -31.47M | EV / Sales 2021 * | - |
Net cash position 2021 * | - 0 | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 38.12% |
1st Jan change | Capi. | |
---|---|---|
+25.61% | 46.56B | |
+44.76% | 41.67B | |
-0.46% | 41.16B | |
+34.33% | 32.4B | |
+20.96% | 28.18B | |
-6.35% | 28.1B | |
+49.37% | 14.52B | |
+46.81% | 13.74B | |
+1.89% | 12.17B |